Chemoinformaics analysis of O-Acetyloleanolic aldehyde
| Molecular Weight | 482.749 | nRot | 2 |
| Heavy Atom Molecular Weight | 432.349 | nRig | 28 |
| Exact Molecular Weight | 482.376 | nRing | 5 |
| Solubility: LogS | -6.653 | nHRing | 0 |
| Solubility: LogP | 7.071 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 5 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 35 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 89.1857 |
| nHD | 0 | BPOL | 53.6324 |
| QED | 0.228 |
| Synth | 4.824 |
| Natural Product Likeliness | 3.229 |
| NR-PPAR-gamma | 0.885 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.144 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -5.05 |
| MDCK | 0.0000143 |
| BBB | 0.752 |
| PPB | 0.813368 |
| VDSS | 1.447 |
| FU | 0.0901071 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.139 |
| CYP2c19-inh | 0.061 |
| CYP2c19-sub | 0.82 |
| CYP2c9-inh | 0.208 |
| CYP2c9-sub | 0.113 |
| CYP2d6-inh | 0.796 |
| CYP2d6-sub | 0.074 |
| CYP3a4-inh | 0.871 |
| CYP3a4-sub | 0.726 |
| CL | 3.471 |
| T12 | 0.026 |
| hERG | 0.027 |
| Ames | 0.007 |
| ROA | 0.09 |
| SkinSen | 0.945 |
| Carcinogencity | 0.081 |
| EI | 0.262 |
| Respiratory | 0.981 |
| NR-Aromatase | 0.672 |
| Antiviral | No |
| Prediction | 0.600235 |